
If you have $2,000 sitting in your bank account with no immediate plans for it, it could be worth putting it to work in the share market.
After all, the potential returns on offer from Australian stocks are vastly superior to what you would earn from a savings account.
The good news is that you do not need a large portfolio or a complex strategy to get started. Sometimes, investing a single amount into high-quality businesses and letting time do the heavy lifting can be a sensible approach.
With that in mind, here are two Australian stocks that could be good options for investors with $2,000 to invest right now.
CSL Ltd (ASX: CSL)
Although recent history might suggest otherwise, CSL remains one of the highest-quality businesses on the Australian share market.
It is a global biotech giant with a specialty in plasma therapies, specialty pharmaceuticals, and vaccines. This means it is operating in areas of healthcare where demand is driven by long-term medical needs rather than economic cycles. This gives CSL a level of resilience that few companies can match.
What sets CSL apart from many others is its ability to reinvest for growth. It consistently directs capital into research, manufacturing capacity, and global expansion, which has supported decades of earnings growth. In FY 2025, CSL spent US$1.36 billion on R&D and will be spending a similar amount again in FY 2026. This ensures that it has a pipeline of potential therapies to entrench its position and drive growth over the long term.
For investors looking to put $2,000 into an Australian stock they can hold with long-term confidence, I think CSL could be worth considering.
I’m not alone with this view. The team at Morgans has a buy rating and $249.51 price target on its shares. This implies potential upside of over 40% for investors.
REA Group Ltd (ASX: REA)
Another Australian stock that could be a good pick for the $2,000 is REA Group.
It is the company behind one of Australia’s most powerful digital platforms. REA Group’s realestate.com.au has become the default destination for property buyers, sellers, and agents, giving REA a dominant position in online real estate advertising. That dominance creates strong pricing power and valuable data advantages.
Looking ahead, REA’s growth is not solely tied to property volumes. The company continues to expand its suite of products and services, increasing revenue per listing and deepening its role across the property transaction process. Over time, this creates opportunities for earnings growth even in softer housing markets.
UBS thinks it could be an Australian stock to snap up. It has a buy rating and $255.00 price target on its shares. This is 35% higher than current levels.
The post Top Australian stocks to buy with $2,000 right now appeared first on The Motley Fool Australia.
Should you invest $1,000 in CSL right now?
Before you buy CSL shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 1 Jan 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- 3 quality ASX healthcare shares worth buying now
- 3 of the best ASX 200 shares to buy and hold until 2036
- Why I think CSL and DroneShield shares are buys for 2026
- 3 ASX 200 shares I’d trust if I couldn’t check my portfolio for a year
- Are these 2 ASX 200 media shares a bargain?
Motley Fool contributor James Mickleboro has positions in CSL and REA Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
Leave a Reply